New compounds display strong therapeutic potential for cystic fibrosis Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team has recently discovered two new compounds that could be used to treat patients carrying the most common mutation. By means of virtual screening and experiments on mice and human cells in culture, the scientists were able to screen 200,000 compounds and selected two that allowed ...
Sept. 30, 2013 - Science Daily